Supplementary figure 1 from Spectrum of Response to Platinum and PARP Inhibitors in Germline <i>BRCA</i>–Associated Pancreatic Cancer in the Clinical and Preclinical Setting

Abstract

&lt;p&gt;In vivo growth kinetics and EVOC efficacy in acquired resistance model&lt;/p&gt;